carvedilol has been researched along with dobutamine in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 15 (75.00) | 29.6817 |
| 2010's | 4 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chen, EC; Chien, HC; Giacomini, KM; Huang, Y; Khuri, N; Liang, X; Sali, A; Stecula, A; Yee, SW | 1 |
| Bristow, MR; Lindenfeld, J; Lowes, BD | 1 |
| Hirao, K; Iwado, Y; Kohno, M; Kondo, I; Matsuo, H; Mizushige, K; Nozaki, S; Senda, S | 1 |
| Bristow, MR; Eichhorn, EJ; Gilbert, EM; Lowes, BD; Tsvetkova, T | 1 |
| Bristow, MR; D'Aloia, A; Dei Cas, L; Metra, M; Muneretto, C; Nodari, S; Robertson, AD | 1 |
| Andersson, B; Bollano, E; Hjalmarson, A; Täng, MS; Waagstein, F | 1 |
| Böhm, M; Finkler, N; Kindermann, M; Läer, S; Maack, C; Schäfers, HJ; Schaller, S; Schmidt, KI; Wuttke, H | 1 |
| Ichikawa, S; Kasama, S; Kumakura, H; Kurabayashi, M; Suzuki, T; Takayama, Y; Tange, S; Toyama, T | 1 |
| Bax, JJ; Boersma, E; de Roos, A; Kaandorp, TA; Lamb, HJ; van der Wall, EE; Viergever, EP | 1 |
| Ebisawa, T; Fujimoto, K; Hori, Y; Maekawa, S; Uechi, M; Yamano, S | 1 |
| Dodouras, T; Farmakis, D; Filippatos, G; Kremastinos, DT; Paraskevaidis, I; Parissis, JT; Tsiapras, D | 1 |
| Vural, M | 1 |
| Dalampiras, P; Kelepeshis, G; Sitafidis, G; Skoularigis, J; Triposkiadis, F | 1 |
| Akyuz, S; Alioglu, E; Bozkaya, YT; Duygu, H; Gunduz, R; Kirilmaz, B; Ozdogan, O; Payzin, S; Turk, U; Turkoglu, C | 1 |
| Katoh, C; Komatsu, H; Kuge, Y; Morita, K; Naya, M; Nishijima, K; Tamaki, N; Tsukamoto, T; Tsutsui, H; Yamada, S | 1 |
| Balk, AH; Caliskan, K; Constantinescu, AA; Jewbali, L; Manintveld, OC; van Domburg, R | 1 |
1 review(s) available for carvedilol and dobutamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 trial(s) available for carvedilol and dobutamine
| Article | Year |
|---|---|
Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aged; Carbazoles; Cardiotonic Agents; Carvedilol; Chronic Disease; Dobutamine; Drug Interactions; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Male; Metoprolol; Middle Aged; Propanolamines; Radionuclide Angiography; Severity of Illness Index; Time Factors; Treatment Outcome | 2002 |
Different responses to dobutamine in the presence of carvedilol or metoprolol in patients with chronic heart failure.
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiotonic Agents; Carvedilol; Chronic Disease; Cross-Over Studies; Dobutamine; Dopamine; Echocardiography, Stress; Heart Failure; Humans; Metoprolol; Middle Aged; Propanolamines; Single-Blind Method; Treatment Outcome | 2003 |
Carvedilol but not metoprolol reduces beta-adrenergic responsiveness after complete elimination from plasma in vivo.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Alleles; Allosteric Site; Binding Sites; Carbazoles; Cardiac Output; Carvedilol; Cross-Over Studies; Cytochrome P-450 CYP2D6; Dobutamine; Echocardiography, Stress; Genotype; Heart Atria; Heart Rate; Humans; Inactivation, Metabolic; Isoproterenol; Male; Metoprolol; Propanolamines; Protein Binding; Receptors, Adrenergic, beta; Up-Regulation | 2004 |
Dobutamine stress 99mTc-tetrofosmin quantitative gated SPECT predicts improvement of cardiac function after carvedilol treatment in patients with dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Dobutamine; Exercise Test; Female; Gated Blood-Pool Imaging; Humans; Male; Middle Aged; Prognosis; Propanolamines; Recovery of Function; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Dysfunction, Left | 2004 |
Cardiovascular effects of a phosphodiesterase III inhibitor in the presence of carvedilol in dogs.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Antagonists; Animals; Blood Pressure; Carbazoles; Cardiovascular Physiological Phenomena; Carvedilol; Cyclic Nucleotide Phosphodiesterases, Type 3; Dobutamine; Dogs; Dopamine; Drug Interactions; Female; Heart Rate; Male; Milrinone; Myocardial Contraction; Propanolamines | 2006 |
Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Carbazoles; Cardiotonic Agents; Carvedilol; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Propanolamines; Pyridazines; Simendan; Time Factors; Treatment Outcome | 2008 |
13 other study(ies) available for carvedilol and dobutamine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Discovery of Competitive and Noncompetitive Ligands of the Organic Cation Transporter 1 (OCT1; SLC22A1).
Topics: Drug Discovery; HEK293 Cells; Humans; Ligands; Molecular Docking Simulation; Organic Cation Transporter 1; Small Molecule Libraries | 2017 |
Hypotension with dobutamine: beta-adrenergic antagonist selectivity at low doses of carvedilol.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Blood Pressure; Carbazoles; Cardiac Output; Carvedilol; Dobutamine; Drug Interactions; Fatal Outcome; Heart Failure; Heart Rate; Humans; Hypotension; Male; Propanolamines | 1999 |
Ultrasonic tissue characterization can predict beta-blocker efficacy in dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Case-Control Studies; Dobutamine; Echocardiography, Doppler; Female; Heart; Humans; Iodine Radioisotopes; Male; Middle Aged; Propanolamines; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2001 |
Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Carbazoles; Cardiac Output; Carvedilol; Dobutamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Milrinone; Phosphodiesterase Inhibitors; Propanolamines; Prospective Studies; Pulmonary Wedge Pressure; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 2001 |
Prediction of beneficial effect of beta blocker treatment in severe ischaemic cardiomyopathy: assessment of global left ventricular ejection fraction using dobutamine stress cardiovascular magnetic resonance.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Dobutamine; Feasibility Studies; Heart Failure; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Myocardial Ischemia; Propanolamines; Stroke Volume; Treatment Outcome; Ventricular Dysfunction, Left | 2005 |
Carvedilol improves left atrial and left ventricular function and reserve in dilated cardiomyopathy after 1 year of treatment.
Topics: Adrenergic beta-Antagonists; Adult; Atrial Function, Left; Carbazoles; Cardiomyopathy, Dilated; Cardiotonic Agents; Carvedilol; Dobutamine; Echocardiography, Doppler; Echocardiography, Stress; Female; Follow-Up Studies; Heart Atria; Heart Ventricles; Humans; Infusions, Intravenous; Male; Middle Aged; Propanolamines; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2007 |
[Role of the drug interaction between carvedilol and dobutamine in inducing of severe hypotension in a case with acute coronary syndrome].
Topics: Aged; Carbazoles; Cardiotonic Agents; Carvedilol; Diagnosis, Differential; Dobutamine; Drug Interactions; Female; Humans; Hypotension; Myocardial Infarction; Propanolamines; Vasodilator Agents | 2007 |
Hemodynamic effects of dobutamine in patients with an exacerbation of chronic systolic heart failure treated with low doses of carvedilol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Carbazoles; Cardiotonic Agents; Carvedilol; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Propanolamines; Stroke Volume | 2008 |
Myocardial beta-adrenergic receptor density assessed by 11C-CGP12177 PET predicts improvement of cardiac function after carvedilol treatment in patients with idiopathic dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Aged; Carbazoles; Carbon Radioisotopes; Cardiomyopathy, Dilated; Carvedilol; Dobutamine; Exercise Test; Female; Humans; Male; Middle Aged; Myocardium; Positron-Emission Tomography; Prognosis; Propanolamines; Radiopharmaceuticals; Receptors, Adrenergic, beta; Stroke Volume | 2009 |
Weaning from inotropic support and concomitant beta-blocker therapy in severely ill heart failure patients: take the time in order to improve prognosis.
Topics: Adrenergic beta-Antagonists; Adult; Bisoprolol; Carbazoles; Cardiotonic Agents; Carvedilol; Dobutamine; Echocardiography; Enoximone; Female; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Prognosis; Propanolamines; Retrospective Studies; Survival Rate; Ventilator Weaning | 2014 |